Precision medicine can provide tailored care to certain patients, but few studies have investigated how these treatments impact African Americans.
The African American Pharmacogenomic Consortium Network Transdisciplinary Collaborative Center (ACCOuNT TCC), a partnership between ITM investigators and Northwestern University, is pleased to announce a new funding program designed to connect community stakeholders with researchers to develop African American cardiovascular pharmacogenomics – or how a person’s genes impact their reaction to drugs for the heart and blood vessels – and spread the word about the importance of using a person’s genetic information to treat cardiovascular disease.
ACCOuNT will fund up to $25,000 for projects that:
- engage community leaders in this research
- develop a precision medicine initiative for African Americans to see if the practice is as helpful to them as those of European descent
- support researchers who are studying how African American genetics impact responses to medications
Deadline: 5 p.m. September 15, 2017.